Senior insider sale
Chief Executive Officer at MAZE THERAPEUTICS, INC. — senior position signals high conviction
$3.76M
138K shares
COLOMA JASON V plans to sell 138K shares of MAZE THERAPEUTICS, INC. valued at approximately $3.76M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Gift
NA
Gift
NA
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/22/2021 | Gift NA | 2.59K | Gift |
9/22/2021 | Gift NA | 31.91K | Gift |
| Total | 34.50K | ||
Completed
Units to sell
2.59K
Market value
$69.3K
Units to sell
31.91K
Market value
$853.0K
Units to sell
31.91K
Market value
$956.5K
Units to sell
2.59K
Market value
$77.7K
Units to sell
23.86K
Market value
$621.7K
Units to sell
2.04K
Market value
$53.0K
Units to sell
1.95K
Market value
$50.8K
Units to sell
553.00
Market value
$14.5K
Units to sell
6.09K
Market value
$159.5K
Planned — Approximate Date
Units to sell
34.50K
Market value
$908.1K
Units
138K
Value
$3.76M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/3/2026 | 2.59K | $69.3K | — | Completed |
8/3/2026 | 31.91K | $853.0K | — | Completed |
7/1/2026 | 31.91K | $956.5K | — | Completed |
7/1/2026 | 2.59K | $77.7K | — | Completed |
6/23/2026 | 23.86K | $621.7K | — | Completed |
6/22/2026 | 2.04K | $53.0K | — | Completed |
6/22/2026 | 1.95K | $50.8K | — | Completed |
6/1/2026 | 553.00 | $14.5K | — | Completed |
6/1/2026 | 6.09K | $159.5K | — | Completed |
| Planned — Approximate Date | ||||
9/1/2026 | 34.50K | $908.1K | Nasdaq | Planned |
| Total | 138K | $3.76M | ||